Uric acid as a risk factor for cardiovascular disease

QJM: An International Journal of Medicine

Volumn 93, Issue 11, 2000, Pages 707-713

  Waring, W S ^a   Webb, D J ^a   Maxwell, S R J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATASE; CHOLESTEROL; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; METHYLXANTHINE; NUCLEIC ACID; TRIACYLGLYCEROL; URIC ACID; XANTHINE OXIDASE;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY RISK; DISEASE MARKER; ENZYME ACTIVITY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; HYPERURICEMIA; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; PURINE METABOLISM; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; URIC ACID BLOOD LEVEL;

EID: 0033709568     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/93.11.707     Document Type: Review

References (60)

1. Is raised serum uric acid a cause of cardiovascular disease or death?
2. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution
3. Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: The bogalusa heart study
4. The management of gout
5. Hyperuricemic nephropathies
6. Localization of the human urate oxidase gene (UOX) to 1p22
7. Two independent mutational events in the loss of urate oxidase
8. Hyperuricemia: Relationship to hypercholesterolemia and acute myocardial infarction
9. Serum uric acid and coronary heart disease
10. Serum uric acid levels in cardiovascular diseases
11. Uric acid and coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome
12. Associations of plasma high-density lipoprotein cholesterol with clinical chemistry data
13. Evaluation of renal handling of uric acid in essential hypertension: Hyperuricemia related to decreased urate secretion
14. Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries
15. Serum uric acid and cardiovascular events in successfully treated hypertensive patients
16. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
17. Does treatment-mediated increase in serum uric acid reduce the cardioprotective effect of diuretics in hypertensive patients?
18. Uric acid as an independent risk factor in the treatment of hypertension
19. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World health organization monitoring trends and determinants in diseases
20. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden
21. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus
22. Serum urate and the risk of major coronary heart disease events
23. Serum uric acid: Its association with other risk factors and with mortality in coronary heart disease
24. Hyperuricemia as a risk factor for cardiovascular mortality
25. Serum uric acid and risk for cardiovascular disease and death: The framingham heart study
26. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: The ARIC study. Atherosclerosis risk in communities
27. Predictors of atherosclerosis in the Honolulu Heart Program I. Biologic, dietary and lifestyle characteristics
28. The role of adenosine in the regulation of coronary blood flow
29. Intravascular source of adenosine during forearm ischemia in humans. Implications for reactive hyperemia
30. Contribution of endothelium and cardiomyocytes to hypoxia-induced adenosine release
31. Cardiovascular effects of adenosine
32. Capillary endothelial transport of uric acid in guinea pig heart
33. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery
34. Evaluation of serum uric acid changes in different forms of hepatic vascular inflow occlusion in human liver surgeries
35. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: Potential mechanisms for free radical generation
36. Tourniquet-induced exsanguination in patients requiring lower limb surgery. An ischemia-reperfusion model of oxidant and antioxidant metabolism
37. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure
38. Insulin as a vascular hormone: Implications for the pathophysiology of cardiovascular disease
39. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension
40. Effect of insulin or renal sodium and uric acid handling in essential hypertension
41. The effect of insulin on renal sodium metabolism. A review with clinical implications
42. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men
43. The pharmacology of human blood vessels in vivo
44. Nitric oxide in the human cardiovascular system- SKB lecture 1997
45. Oxidative stress and cardiovascular disease
46. Endothelial dysfunction and hypertension
47. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis
48. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus
49. Nitrosation of uric acid by peroxynitrite. Formation of a vasoactive nitric oxide donor
50. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: A study using uric acid
51. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro
52. Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein
53. Mechanisms of vascular damage in gout and oxalosis: Crystal induced, granulocyte mediated, endothelial injury
54. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells
55. The fever of gout: Urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes
56. Systemic response to local urate crystal induced inflammation in man: A possible model to study the acute phase response
57. Uric acid in chronic heart failure: A marker of chronic inflammation
58. Identification of uric acid in aortic aneurysms and atherosclerotic artery
59. Allopurinol improves endothelial dysfunction in patients with chronic heart failure
60. Effect of local hyperuricaemia on endothelial function in the human forearm vascular bed